Ann: FY21 Q3 Conference Call, page-57

Hi Everyone,
I thought Mikebrissey summarised things quite nicely. This quarter's growth was minimal and I did not have high hopes (hoping at least $3m), but my sentiment will still be a BUY at this stage, as I plan to hold until end of next calendar year (2022) if things don't improve. I applaud the questions asked within the call, as they were all the things that were on my mind as well. I am very keen to see this April period, and would rather see it as still a shareholder at this point of time. My points:
- No more capital raising apparently (short term)
- April was a record month (however, can't comment on the quarter)
- Q3 Deals Moving into Q4 (Sceptism, as this has been said in the past)
- Share price down potentially due to lack of research provided for institutes willing to invest.
- Share price down potentially due to lack of growth/revenue guidance.
- Small/Mid clients lost - products becoming more enterprise focus.
- No more legal fees.
- Challenging covid-19 environment with selling enterprise deals.
- Deals can take 6 to 9 months. (I wanted to ask about the hurdles, but i got cut off lol)
- Market/Shareholds unhappy about the fluff from Karl. Language needs to be more clear/accurate and not just ambiguous motivation. i.e "We have a huge pipeline. Yeah... I hope your not just making metaphors for something else"

There was quite a bit, but that's what I gathered. I wish everyone the best and i totally respect everyone's decision. However, I feel like I will keep my rod in the water a little longer.